Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

GR-144053 enhances suppression of neointima formation by losartan following vascular injury

Jan. 5, 1998

NOS inhibitors prepared at Ono

Jan. 5, 1998

Warner-Lambert describes water-soluble, nonpeptide ET antagonists

Jan. 2, 1998

New orally active antihypertensive compounds prepared at Rotta

Dec. 31, 1997

IBT-9302 inhibits multiple growth factor-induced SMC proliferation and migration

Dec. 30, 1997

Teveten cleared for U.S. marketing

Dec. 29, 1997

ACAT and lipid peroxidation inhibitors prepared at Tanabe Seiyaku

Dec. 24, 1997

Cytel initiates registration trials of Cylexin in newborns

Dec. 24, 1997

VasoCare therapy successfully completes E.U. regulatory approval audit

Dec. 22, 1997

New warnings added to Posicor labeling

Dec. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...